# Perpetual Medicines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/perpetual-medicines

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.perpetualmeds.com
- Total disclosed funding: $8M
- Latest round: Seed (Dec 1, 2023)
- Investors on record: 1

## About

Founded in 2023 and based in Shanghai, China, Perpetual Medicines is a pharmaceutical technology company that focuses on the research and development of peptide drugs. In December 2023, the firm raised USD 8 million in seed funding led by new investor Chengwei Capital. Kerry L. Blanchard, the company's co-founder, chairman and chief executive officer, previously served as chief executive officer of Everest Medicines and chief scientific officer of Innovent. The company also has operations in Boston, USA.

The company's main products include computational design-automated synthesis of peptide drug discovery platforms and peptide drugs. Its products are used in oncology, autoimmune diseases and metabolic diseases.

## Funding rounds

- Seed, Dec 1, 2023, $8M — Chengwei Capital

## Investors

- Chengwei Capital (https://capitalatlas.ai/funds/chengwei-capital) — Seed